Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy. - Test2 - elhamkhani - TriplyDB

Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.

Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.

http://www.wikidata.org/entity/Q38781022

about

Traumatic brain injury results in acute rarefication of the vascular network.Neurovascular Specifications in the Alzheimer-Like Brain of Mice Affected by Focal Cerebral Ischemia: Implications for Future Therapies.Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease.Endocannabinoid system in neurodegenerative disorders.Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease.Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists.Role of cortical microbleeds in cognitive impairment: In vivo behavioral and imaging characterization of a novel murine model.Melatonin successfully rescues hippocampal bioenergetics and improves cognitive function following drug intoxication by promoting Nrf2-ARE signaling activity.Pharmacogenetics of Vascular Risk Factors in Alzheimer's Disease.Within the Brain: The Renin Angiotensin System.Pharmacologically induced impairment of neurovascular coupling responses alters gait coordination in mice.Demonstration of impaired neurovascular coupling responses in TG2576 mouse model of Alzheimer's disease using functional laser speckle contrast imaging.

P2860

Q36319052-12ED0985-BB60-4A71-856B-22742030CA59 Q38663632-218F4571-C6D1-4DE5-BE96-6A49781242BB Q38781028-6DCFDB68-AFB5-4311-8DA6-D7D6226F9CB2 Q39368845-423E6667-D76E-449A-A33B-B251E0812BA9 Q39444002-321E4D75-E9ED-4D78-9ADA-2113166B3614 Q41105693-BF8B24B2-07A1-4F6F-8999-F428B821E3B9 Q47864495-BF170193-9B11-4ECB-9518-C68FA82BCA34 Q48180220-FEA0218B-DE4D-4470-B45F-C85A7C5FCFC2 Q50190372-F5AD08AD-CF48-4ABB-9AD9-4F1948B7982B Q51762826-A06228A3-B1BE-4F5E-BF75-EDBF7312728E Q55028803-F8E177BB-FAA2-4575-BBA9-860C9AD80AA4 Q55054299-A3CF1727-64CA-4AAD-94F5-BFF6C6EA7751

P2860

Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.

http://www.wikidata.org/entity/Q38781022

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Neurovascular and Cognitive fa ...... its of Cardiovascular Therapy.

@en

type

label

Neurovascular and Cognitive fa ...... its of Cardiovascular Therapy.

@en

prefLabel

Neurovascular and Cognitive fa ...... its of Cardiovascular Therapy.

@en

P1433

Q38781022-AEB15675-D02C-4C1D-B13F-8C8B750C3B32

P1476

Q38781022-6CED9919-98C8-4F6E-8D44-6CE5E2181212

P2093

Q38781022-43AA11B8-B18A-43BD-B6FD-45749EB9E972

Q38781022-A2D5D2DA-18C0-400B-AA03-E8ADEE6C6221

Q38781022-B6ED8361-7939-45A2-9F23-92763D50BCB2

Q38781022-D80E177F-CFDF-4AB3-965F-6257FA020941

P2860

Q38781022-002AA146-AF53-4812-8190-6223051052E5

Q38781022-017FB469-E7C4-4B8A-BA4B-A1FC9149FD65

Q38781022-01CB8F73-1892-431B-A6DD-855F91BA5B6B

Q38781022-033D1821-AEAD-4B45-B723-86EEB16CE374

Q38781022-042692A9-4D3D-4256-8504-550DBA66CAC1

Q38781022-04DB3D50-9D71-429B-B64F-8D33005057C8

Q38781022-050C10DE-CC0A-4F7E-8C1E-1A8AB650D610

Q38781022-0776D6F3-8768-4DBF-8293-34A27954DF72

Q38781022-0AF2593A-1849-4504-AD34-EF3ACE40BC38

Q38781022-0F39DD35-16CE-4760-84FB-276A9B2B81A5

P2888

Q38781022-FBEC89A6-8470-4E0C-A68B-2F21ADD6F785

P304

Q38781022-981F74E4-C311-4E27-A08A-1B0392032CC7

P31

Q38781022-8F2544CC-596E-435D-A118-9CDFEA98FF6F

P356

Q38781022-6A6762CD-5315-4FB9-874B-95ABE5CEADEF

P433

Q38781022-FDAF30AD-AF02-49CD-81A9-BCFB30BBCB53

P478

Q38781022-C42CB6C8-3643-4C4D-A832-E3776C2E937F

P577

Q38781022-123B282C-644B-4BD8-905E-5C8E83062278

P6179

Q38781022-9D1DBEC7-99DF-4F79-85E5-8645D45E0296

P698

Q38781022-47B2B3E2-4542-4F77-8840-2C6219756E7E

P921

Q38781022-5FA96AD3-CC8C-405D-93E6-DE16B3D94A81

P356

S10571-015-0285-4

P1433

Cellular and Molecular Neurobiology

P1476

Neurovascular and Cognitive fa ...... its of Cardiovascular Therapy.

@en

P2093

Brice Ongali

http://www.w3.org/2001/XMLSchema#string

Edith Hamel

http://www.w3.org/2001/XMLSchema#string

Jessika Royea

http://www.w3.org/2001/XMLSchema#string

Xin-Kang Tong

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

Pleiotropic effects of statins

Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease

Clearance systems in the brain-implications for Alzheimer disease

Vascular aspects of cognitive impairment and dementia

The pathobiology of vascular dementia

Immunotherapeutic approaches for Alzheimer's disease

The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases

P2888

s10571-015-0285-4

P304

219-232

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10571-015-0285-4

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1040712679

http://www.w3.org/2001/XMLSchema#string

P698

26993506

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease